Ihr neues Infoportal.

ECCMID 2023 - REAL-WORLD-DATEN

COVID-19

REDPINE Factsheet

COVID-19

CROI 2023 - Real-World-Daten

COVID-19 frühzeitig therapieren, Risiken minimieren

COVID-19

Veklury Pocket Guide

Angaben zur klinischen Anwendung

COVID-19

ACTT-1 Factsheet

Adaptive COVID-19 Treatment Trial (ACTT-1) des National Institute of Allergy and Infectious Diseases…

COVID-19

PINETREE Factsheet

Phase-III-Studie „PINETREE“

COVID-19

Santos, J. R. et al: The REDPINE Study: Efficacy and Safety of Remdesivir in People With Moderately and Severely Reduced Kidney Function Hospitalised for COVID-19 Pneumonia

15.-18.04.2023 / ECCMID

COVID-19

Lee, E. et al: Remdesivir Reduces Readmission in Immunocompromised Adult Patients Hospitalised With COVID 19

15.-18.04.2023 / ECCMID

COVID-19

Mozaffari, E. et al: Remdesivir is associated with decreased mortality in hospitalised COVID-19 patients requiring high-flow oxygen in the United States

15.-18.04.2023 / ECCMID

COVID-19

Mozaffari, E. et al: Immunocompromised patients hospitalized for COVID-19 in the United States: evolving patient characteristics and clinical outcomes across emerging variants

15.-18.04.2023 / ECCMID

COVID-19

Mozaffari, E. et al: Remdesivir is associated with lower mortality in cancer patients hospitalized for COVID-19 across emerging variants

15.-18.04.2023 / ECCMID

COVID-19

Gupta, R. S. et al: Remdesivir Reduced the Hazard of Hospital Readmission in People With COVID-19 Admitted to the ICU While Delta and Omicron Were de Predominant Circulation Variants

15.-18.04.2023 / ECCMID

COVID-19

Mozaffari, E. et al: Remdesivir reduces mortality in hospitalized COVID 19 patients across variant eras

19.-22.02.2023 / CROI

COVID-19

Mozaffari, E. et al: Remdesivir reduces mortality in immunocompromised patients hospitalized vor COVID 19

19.-22.02.2023 / CROI

COVID-19

Mozaffari, E. et al: Remdesivir is associated with reduced readmission after COVID 19 hospitalization

19.-22.02.2023 / CROI

COVID-19

Humeniuk R. et al.: Pharmacokinetics Inform Remdesivir Dosing for Patients With Severe Renal Impairment

19.-22.02.2023 / CROI

COVID-19